$CDNA news
The latest CDNA stock news: headlines, filings, AI summaries and sentiment for $CDNA, updated around the clock.
- Piper Sandler Initiates Coverage of CareDx with Overweight Rating and $100 Price Target
- CareDx Shares Surge 22% Following Strong Q3 Growth and Raised Guidance
- CareDx Reports Strong Q3 2026 Results with Significant Revenue Growth and Raised Full-Year Guidance
- CareDx Raises 2026 Revenue Guidance Amid Expansion into Oncology and Cell Therapy
- Tech Stocks Face Pressure as Amazon and Intel Results Weigh on Nasdaq Futures
- CareDx Reports Q3 Earnings Beat with Significant Revenue Growth and Raised 2026 Guidance
- CareDx, Inc. - 10-Q Filing
- CareDx, Inc. - 8-K Filing
- Royce Micro-Cap Trust (RMT) Reports Performance and Portfolio Data as of September 30, 2026
- CareDx, Inc. - 8-K Filing
- CareDx Shares Rise Over 9% After Guidance Increase
- CareDx Announces Strong Q2 Results, Raises Full-Year Guidance
- CareDx Reports Strong Q2 Earnings with Revenue Growth of 52%
- CareDx Shares Rise on Strong Q2 Results and Raised Guidance
- CareDx Raises Revenue Guidance for 2026 and Reports Q2 Earnings Beat
- CareDx, Inc. - 8-K Filing
- CareDx Surges After Medicare Finalizes Transplant Testing Coverage Policy
- CareDx, Inc. - 8-K Filing
- U.S. Supreme Court Declines to Hear CareDx's Appeal Against Natera
- CareDx CEO Sells Shares Worth $425K
- CareDx Reports 39% Q1 Revenue Growth, Expands into Oncology with Naveris Acquisition
- CareDx Announces Q1 2026 Earnings Call Highlights and Strategic Updates
- CareDx (CDNA) Q1 2026 Earnings Call Transcript Released
- CareDx (CDNA) Q2 2025 Earnings Call Transcript Released
- CareDx Acquires Naveris for $260M to Expand Precision Medicine Capabilities
- CareDx Reports Q1 2026 Earnings Results
- CareDx Reports Q2 2025 Earnings with Revenue Growth and Policy Concerns